Glanbia plc (FRA:GL9)

Germany flag Germany · Delayed Price · Currency is EUR
14.27
+0.02 (0.14%)
Last updated: Dec 5, 2025, 8:03 AM CET
1.64%
Market Cap 3.63B
Revenue (ttm) 3.35B
Net Income (ttm) 102.54M
Shares Out n/a
EPS (ttm) 0.39
PE Ratio 35.37
Forward PE 12.19
Dividend 0.41 (2.87%)
Ex-Dividend Date Aug 21, 2025
Volume n/a
Average Volume 25
Open 14.27
Previous Close 14.25
Day's Range 14.27 - 14.27
52-Week Range 8.90 - 15.50
Beta n/a
RSI 51.51
Earnings Date Feb 25, 2026

About Glanbia

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; pro... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 5,791
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GL9
Full Company Profile

Financial Performance

In 2024, Glanbia's revenue was $3.84 billion, a decrease of -29.23% compared to the previous year's $5.43 billion. Earnings were $164.70 million, a decrease of -52.18%.

Financial numbers in USD Financial Statements

News

There is no news available yet.